N
NeoGenomics, Inc. (NEO)
NCM – Real vaqt narxi. Valyuta: USD
8.75
+0.09 (1.04%)
Yopilishda: May 12, 2026, 4:00 PM EDT
8.77
+0.02 (0.23%)
Bozor oldidan: May 13, 2026, 6:23 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
8.75
+0.09 (1.04%)
Yopilishda: May 12, 2026, 4:00 PM EDT
8.77
+0.02 (0.23%)
Bozor oldidan: May 13, 2026, 6:23 AM EDT
NeoGenomics, Inc. Qo'shma Shtatlar va Buyuk Britaniyada saratonga ixtisoslashgan diagnostika laboratoriyalari tarmog'ini boshqaradi. Kompaniya kasalxonalar, akademik markazlar, patologlar, onkologlar, klinitsistlar, farmatsevtika kompaniyalari va klinik laboratoriyalarga diagnostika xizmatlarini taklif etadi. Shuningdek, u normal va anormal xromosomalar va ularning kasalliklar bilan bog'liqligini o'rganish uchun sitogenetika diagnostikasi xizmatlarini; xromosomalardagi ma'lum DNK ketma-ketliklari va genlarning mavjudligini yoki yo'qligini aniqlash va joylashishiga qaratilgan lyuminestsent in situ gibridizatsiya diagnostikasi xizmatlarini; hujayra populyatsiyalari xususiyatlarini o'lchash uchun oqim sitometriya diagnostikasi xizmatlarini; va to'qima kesmalarida hujayra oqsillarini joylashtirish, shuningdek, mijozlarga skanerlangan slayd-preparatlarni vizualizatsiya qilish va turli bo'yoqlar uchun miqdoriy tahlilni amalga oshirish imkonini berish uchun immunogistokimyo va raqamli tasvirlash diagnostikasi xizmatlarini taqdim etadi. Muxar, kompaniya molekulyar darajada DNK va/yoki RNK, shuningdek, genlarning tuzilishi va funksiyasini tahlil qilishga qaratilgan molekulyar diagnostika xizmatlarini; diagnostika maqsadida patolog tomonidan mikroskop ostida hujayralarni tahlil qilish jarayoni bo'lgan morfologik tahlilni; va farmatsevtika mijozlarining kashfiyot va tijoratlashtirishni qamrab oluvchi onkologiya dasturlarini qo'llab-quvvatlash uchun diagnostika xizmatlarini taklif etadi. Kompaniya 2001 yilda tashkil etilgan va Fort Mayers, Florida shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Abhishek Jain | Executive VP & CFO |
| Mr. Anthony P. Zook | CEO & Director |
| Mr. Clarence Cooper Esq. | Vice President of Compliance & Privacy |
| Mr. Gary Passman | Chief People & Culture Officer |
| Mr. Gregory D. Aunan | Senior VP & Chief Accounting Officer |
| Mr. Kareem M. Saad | Head of Strategy, Business Development & Transformation |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-28 | 8-K | neo-20260428.htm |
| 2026-04-28 | 10-Q | neo-20260331.htm |
| 2026-04-06 | DEF 14A | neo-20260406.htm |
| 2026-02-17 | 8-K | neo-20260217.htm |
| 2026-02-17 | 10-K | neo-20251231.htm |
| 2026-01-12 | 8-K | neo-20260109.htm |
| 2025-12-30 | 8-K | neo-20251223.htm |
| 2025-10-28 | 10-Q | neo-20250930.htm |
| 2025-08-08 | 8-K | neo-20250805.htm |
| 2025-07-29 | 8-K | neo-20250729.htm |
| Mr. Warren Stone | President & COO |
| Ms. Alicia C. Olivo | Executive VP of Business Development, General Counsel & Corporate Secretary |
| Ms. Elizabeth A. Floegel | Chief Digital & Information Officer |
| Ms. Kendra Sweeney | Vice President of Investor Relations & Communications |